The members of the American Association for Cancer Research (AACR) have elected Michael A. Caligiuri, MD, as their President-Elect for 2016–2017. He officially became President-Elect at the AACR Annual Meeting 2016, held in New Orleans, April 16–20, and will assume the presidency in April 2017 at the Annual Meeting.
Dr. Caligiuri is Director of The Ohio State University Comprehensive Cancer Center and CEO of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He holds the John L. Marakas Nationwide Insurance Enterprise Foundation Chair in Cancer Research and is a Professor in The Ohio State University College of Medicine Department of Molecular Virology, Immunology, and Medical Genetics, as well as the Department of Internal Medicine.
Dr. Caligiuri is a physician-scientist, known for his work in immunology that is focused on human natural killer cells and their modulation for the treatment of leukemia, myeloma, and glioblastoma. Well over 1,500 cancer patients have been treated on clinical protocols that have emanated from his laboratory.
He will work collaboratively with the AACR board of directors and the AACR membership, which includes more than 35,000 members in 104 countries, to further the association’s mission to prevent and cure cancer through research, education, communication, and collaboration.
“For over a century, AACR has been an unwavering catalyst for advancing cancer research in meaningful ways: fostering collaboration among scientists and physicians, accelerating the dissemination of cancer discoveries, and supporting the education and training of young cancer researchers. I am humbled and tremendously honored to be elected by my peers to serve as AACR President-Elect,” said Dr. Caligiuri. “This is an especially exciting time as we all work to forge new and innovative models of collaboration between academia, industry, the government, and the community—something I am certain AACR can play a pivotal role in facilitating.”
Dr. Caliguri is also President of the Society of Natural Immunity, Chair of the Institute of Medicine’s National Cancer Policy Forum, and a member or chair of the external boards for 12 of the nation’s cancer centers. He is a Past President of the Association for American Cancer Institutes, as well as a former Councilor and Executive Committee Member of the American Society of Hematology, past member of the Board of Scientific Advisors and the Board of Scientific Counselors of the National Cancer Institute (NCI), and Past Vice Chair of the Scientific Advisory Board of the Cure for Lymphoma Foundation.
Dr. Caligiuri joined the faculty at Ohio State in 1997. He served on the faculty as a professor and medical oncologist specializing in hematologic malignancies at Roswell Park Cancer Institute from 1990–1997.■